The lectin-like oxidized low-density lipoprotein receptor-1 and its soluble form: Cardiovascular implications

Journal of Atherosclerosis and Thrombosis

Volumn 17, Issue 4, 2010, Pages 317-331

  Navarra, Teresa ^a   Del Turco, Serena ^a   Berti, Sergio ^b   Basta, Giuseppina ^a  

^a INSTITUTE OF CLINICAL PHYSIOLOGY   (Italy)

^b G Monasterio Foundation   (Italy)

Author keywords

Atherosclerosis; Lectin like oxidized low density lipoprotein receptor 1; Oxidized low density lipoprotein; Scavenger receptor; Signal transduction

Indexed keywords

ACETYLSALICYLIC ACID; ATORVASTATIN; CD94 ANTIGEN; DECTIN 1; DECTIN 2; GELATINASE B; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERCELLULAR ADHESION MOLECULE 1; INTERSTITIAL COLLAGENASE; LOSARTAN; METFORMIN; MONOCYTE CHEMOTACTIC PROTEIN 1; MULBERRY EXTRACT; NATURAL KILLER CELL RECEPTOR NKG2A; OXIDIZED LOW DENSITY LIPOPROTEIN RECEPTOR 1; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; PRAVASTATIN; REACTIVE OXYGEN METABOLITE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE; SIMVASTATIN; STROMELYSIN; VASCULAR CELL ADHESION MOLECULE 1;

3' UNTRANSLATED REGION; 5' UNTRANSLATED REGION; ACUTE CORONARY SYNDROME; ATHEROGENESIS; ATHEROSCLEROSIS; DOWN REGULATION; ENDOCYTOSIS; ENZYME ACTIVATION; ENZYME INHIBITION; ENZYME REGULATION; GENE OVEREXPRESSION; GENE STRUCTURE; HUMAN; HYPERCHOLESTEROLEMIA; HYPERGLYCEMIA; LIPID PEROXIDATION; MOLECULAR WEIGHT; NONHUMAN; PROTEIN DOMAIN; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; PROTEIN PHOSPHORYLATION; PROTEIN POLYMORPHISM; PROTEIN PROTEIN INTERACTION; PROTEIN STRUCTURE; REVIEW; SIGNAL TRANSDUCTION; SINGLE NUCLEOTIDE POLYMORPHISM; UPREGULATION;

EID: 77953531592     PISSN: 13403478     EISSN: 18803873     Source Type: Journal    
DOI: 10.5551/jat.3228     Document Type: Review

References (118)

1. Badimon JJ, Fuster V, Chesebro JH, Badimon L: Coro-nary atherosclerosis. A multifactorial disease. Circula-tion, 1993; 87: 3-16
2. Berliner JA, Heinecke JW: The role of oxidized lipopro-teins in atherogenesis. Free Radic Biol Med, 1996; 20: 707-727
3. Novelli G, Mango R, Vecchione L, Mariotti E, Borgiani P, Mehta JL, Romeo F: New insights in atherosclerosis research: LOX-1, leading actor of cardiovascular diseases. Clin Ter, 2007; 158: 239-248
4. Kume N, Murase T, Moriwaki H, Aoyama T, Sawamura T, Masaki T, Kita T: Inducible expression of lectin-like oxidized LDL receptor-1 in vascular endothelial cells. Circ Res, 1998; 83: 322-327
5. Ohki I, Ishigaki T, Oyama T, Matsunaga S, Xie Q, Ohnishi-Kameyama M, Murata T, Tsuchiya D, Machida S, Morikawa K, Tate S: Crystal structure of human lec-tin-like, oxidized low-density lipoprotein receptor 1 ligand binding domain and its ligand recognition mode to OxLDL. Structure, 2005; 13: 905-917
6. Kataoka H, Kume N, Miyamoto S, Minami M, Mori-waki H, Murase T, Sawamura T, Masaki T, Hashimoto N, Kita T: Expression of lectinlike oxidized low-density lipoprotein receptor-1 in human atherosclerotic lesions. Circulation, 1999; 99: 3110-3117
7. Oka K, Sawamura T, Kikuta K, Itokawa S, Kume N, Kita T, Masaki T: Lectin-like oxidized low-density ipoprotein receptor 1 mediates phagocytosis of aged/apoptotic cells in endothelial cells. Proc Natl Acad Sci U S A, 1998; 95: 9535-9540
8. Kakutani M, Masaki T, Sawamura T: A platelet-endothe-lium interaction mediated by lectin-like oxidized low-density lipoprotein receptor-1. Proc Natl Acad Sci U S A, 2000; 97: 360-364
9. Shimaoka T, Kume N, Minami M, Hayashida K, Sawamura T, Kita T, Yonehara S: LOX-1 supports adhe-sion of Gram-positive and Gram-negative bacteria. J Immunol, 2001; 166: 5108-1514.
10. Sakurai K, Sawamura T: Stress and vascular responses: endothelial dysfunction via lectin-like oxidized low-den-sity lipoprotein receptor-1: close relationships with oxi-dative stress. J Pharmacol Sci, 2003; 91: 182-186.
11. Dunn S, Vohra RS, Murphy JE, Homer-Vanniasinkam S, Walker JH, Ponnambalam S: The lectin-like oxidized low-density-lipoprotein receptor: a pro-inflammatory factor in vascular disease. Biochem J, 2008; 409: 349-355.
12. Sawamura T, Kume N, Aoyama T, Moriwaki H, Hoshi-kawa H, Aiba Y, Tanaka T, Miwa S, Katsura Y, Kita T, Masaki T: An endothelial receptor for oxidized low-den-sity lipoprotein. Nature, 1997; 386: 73-77.
13. Murase T, Kume N, Kataoka H, Minami M, Sawamura T, Masaki T, Kita T: Identification of soluble forms of lectin-like oxidized LDL receptor-1. Arterioscler Thromb Vasc Biol, 2000; 20: 715-720
14. Kume N, Kita T: Roles of lectin-like oxidized LDL receptor-1 and its soluble forms in atherogenesis. Curr Opin Lipidol, 2001; 12: 419-423
15. Yamanaka S, Zhang XY, Miura K, Kim S, Iwao H: The human gene encoding the lectin-type oxidized LDL receptor (OLR1) is a novel member of the natural killer gene complex with a unique expression profile. Genom-ics, 1998; 54: 191-199.
16. Sobanov Y, Bernreiter A, Derdak S, Mechtcheriakova D, Schweighofer B, Duchler M, Kalthoff F, Hofer E: A novel cluster of lectin-like receptor genes expressed in monocytic, dendritic and endothelial cells maps close to the NK receptor genes in the human NK gene complex. Eur J Immunol, 2001; 31: 3493-3503.
17. Huysamen C, Brown GD: The fungal pattern recogni-tion receptor, Dectin-1, and the associated cluster of C-type lectin-like receptors. FEMS Microbiol Lett, 2009; 290: 121-128.
18. Aoyama T, Sawamura T, Furutani Y, Matsuoka R, Yoshida MC, Fujiwara H, Masaki T: Structure and chro-mosomal assignment of the human lectin-like oxidized low-density-lipoprotein receptor-1 (LOX-1) gene. Bio-chem J, 1999; 339 (Pt 1): 177-184.
19. Hofnagel O, Luechtenborg B, Stolle K, Lorkowski S, Eschert H, Plenz G, Robenek H: Proinflammatory cytokines regulate LOX-1 expression in vascular smooth muscle cells. Arterioscler Thromb Vasc Biol, 2004; 24: 1789-1795
20. Li DY, Zhang YC, Philips MI, Sawamura T, Mehta JL: Upregulation of endothelial receptor for oxidized low- density lipoprotein (LOX-1) in cultured human coro-nary artery endothelial cells by angiotensin II type 1 receptor activation. Circ Res, 1999; 84: 1043-1049.
21. Chen Q, Reis SE, Kammerer C, Craig WY, LaPierre SE, Zimmer EL, McNamara DM, Pauly DF, Sharaf B, Hol-ubkov R, Bairey Merz CN, Sopko G, Bontempo F, Kamboh MI: Genetic variation in lectin-like oxidized low-density lipoprotein receptor 1 (LOX1) gene and the risk of coronary artery disease. Circulation, 2003; 107: 3146-3151
22. Mango R, Clementi F, Borgiani P, Forleo GB, Federici M, Contino G, Giardina E, Garza L, Fahdi IE, Lauro R, Mehta JL, Novelli G, Romeo F: Association of single nucleotide polymorphisms in the oxidised LDL receptor 1 (OLR1) gene in patients with acute myocardial infarc-tion. J Med Genet, 2003; 40: 933-936
23. Ohmori R, Momiyama Y, Nagano M, Taniguchi H, Egashira T, Yonemura A, Nakamura H, Kondo K, Ohsuzu F: An oxidized low-density lipoprotein receptor gene variant is inversely associated with the severity of coronary artery disease. Clin Cardiol, 2004; 27: 641-644.
24. Trabetti E, Biscuola M, Cavallari U, Malerba G, Girelli D, Olivieri O, Martinelli N, Corrocher R, Pignatti PF: On the association of the oxidised LDL receptor 1 (OLR1) gene in patients with acute myocardial infarc-tion or coronary artery disease. Eur J Hum Genet, 2006; 14: 127-130.
25. Morgan TM, Krumholz HM, Lifton RP, Spertus JA: Nonvalidation of reported genetic risk factors for acute coronary syndrome in a large-scale replication study. JAMA, 2007; 297: 1551-1561
26. Knowles JW, Assimes TL, Boerwinkle E, Fortmann SP, Go A, Grove ML, Hlatky M, Iribarren C, Li J, Myers R, Risch N, Sidney S, Southwick A, Volcik KA, Querter-mous T: Failure to replicate an association of SNPs in the oxidized LDL receptor gene (OLR1) with CAD. BMC Med Genet, 2008; 9: 23
27. Biocca S, Falconi M, Filesi I, Baldini F, Vecchione L, Mango R, Romeo F, Federici G, Desideri A, Novelli G: Functional analysis and molecular dynamics simulation of LOX-1 K167N polymorphism reveal alteration of receptor activity. PLoS One, 2009; 4: e4648
28. Mango R, Biocca S, del Vecchio F, Clementi F, Sangi-uolo F, Amati F, Filareto A, Grelli S, Spitalieri P, Filesi I, Favalli C, Lauro R, Mehta JL, Romeo F, Novelli G: In vivo and in vitro studies support that a new splicing iso-form of OLR1 gene is protective against acute myocar-dial infarction. Circ Res, 2005; 97: 152-158
29. Biocca S, Filesi I, Mango R, Maggiore L, Baldini F, Vec-chione L, Viola A, Citro G, Federici G, Romeo F, Novelli G: The splice variant LOXIN inhibits LOX-1 receptor function through hetero-oligomerization. J Mol Cell Cardiol, 2008; 44: 561-570.
30. Kataoka H, Kume N, Miyamoto S, Minami M, Murase T, Sawamura T, Masaki T, Hashimoto N, Kita T: Bio-synthesis and post-translational processing of lectin-like oxidized low density lipoprotein receptor-1 (LOX-1). N-linked glycosylation affects cell-surface expression and ligand binding. J Biol Chem, 2000; 275: 6573-6579.
31. Xie Q, Matsunaga S, Niimi S, Ogawa S, Tokuyasu K, Sakakibara Y, Machida S: Human lectin-like oxidized low-density lipoprotein receptor-1 functions as a dimer in living cells. DNA Cell Biol, 2004; 23: 111-117
32. Ishigaki T, Ohki I, Utsunomiya-Tate N, Tate SI: Chime-ric structural stabilities in the coiled-coil structure of the NECK domain in human lectin-like oxidized low-den-sity lipoprotein receptor 1 (LOX-1). J Biochem, 2007; 141: 855-866.
33. Shi X, Niimi S, Ohtani T, Machida S: Characterization of residues and sequences of the carbohydrate recogni-tion domain required for cell surface localization and ligand binding of human lectin-like oxidized LDL recep-tor. J Cell Sci, 2001; 114: 1273-1282
34. Mitsuoka H, Kume N, Hayashida K, Inui-Hayashiada A, Aramaki Y, Toyohara M, Jinnai T, Nishi E, Kita T: Inter-leukin 18 stimulates release of soluble lectin-like oxi-dized LDL receptor-1 (sLOX-1). Atherosclerosis, 2009; 202: 176-182
35. Li D, Mehta JL: Upregulation of endothelial receptor for oxidized LDL (LOX-1) by oxidized LDL and implica-tions in apoptosis of human coronary artery endothelial cells: evidence from use of antisense LOX-1 mRNA and chemical inhibitors. Arterioscler Thromb Vasc Biol, 2000; 20: 1116-1122
36. Aoyama T, Fujiwara H, Masaki T, Sawamura T: Induc-tion of lectin-like oxidized LDL receptor by oxidized LDL and lysophosphatidylcholine in cultured endothe-lial cells. J Mol Cell Cardiol, 1999; 31: 2101-2114.
37. Murase T, Kume N, Korenaga R, Ando J, Sawamura T, Masaki T, Kita T: Fluid shear stress transcriptionally induces lectin-like oxidized LDL receptor-1 in vascular endothelial cells. Circ Res, 1998; 83: 328-333
38. Nagase M, Abe J, Takahashi K, Ando J, Hirose S, Fujita T: Genomic organization and regulation of expression of the lectin-like oxidized low-density lipoprotein receptor (LOX-1) gene. J Biol Chem, 1998; 273: 33702-33707
39. Nagase M, Ando K, Nagase T, Kaname S, Sawamura T, Fujita T: Redox-sensitive regulation of lox-1 gene expres-sion in vascular endothelium. Biochem Biophys Res Commun, 2001; 281: 720-725
40. Mukai E, Kume N, Hayashida K, Minami M, Yamada Y, Seino Y, Kita T: Heparin-binding EGF-like growth fac-tor induces expression of lectin-like oxidized LDL recep-tor-1 in vascular smooth muscle cells. Atherosclerosis, 2004; 176: 289-296
41. Shiu SW, Tan KC, Wong Y, Leng L, Bucala R: Glycoxi-dized LDL increases lectin-like oxidized low density lipoprotein receptor-1 in diabetes mellitus. Atherosclero-sis, 2009; 203: 522-527
42. Tan KC, Shiu SW, Wong Y, Leng L, Bucala R: Soluble lectin-like oxidized low density lipoprotein receptor-1 in type 2 diabetes mellitus. J Lipid Res, 2008; 49: 1438-1444
43. Chen M, Nagase M, Fujita T, Narumiya S, Masaki T, Sawamura T: Diabetes enhances lectin-like oxidized LDL receptor-1 (LOX-1) expression in the vascular endothe-lium: possible role of LOX-1 ligand and AGE. Biochem Biophys Res Commun, 2001; 287: 962-968
44. Li L, Roumeliotis N, Sawamura T, Renier G: C-reactive protein enhances LOX-1 expression in human aortic endothelial cells: relevance of LOX-1 to C-reactive pro-tein-induced endothelial dysfunction. Circ Res, 2004; 95: 877-883
45. Hara Y, Kusumi Y, Mitsumata M, Li XK, Fujino M. Lysophosphatidylcholine upregulates LOX-1, chemokine receptors, and activation-related transcription factors in human T-cell line Jurkat. J Thromb Thrombolysis, 2008; 26: 113-118.
46. Morawietz H, Duerrschmidt N, Niemann B, Galle J, Sawamura T, Holtz J: Augmented endothelial uptake of oxidized low-density lipoprotein in response to endothe-lin-1. Clin Sci (Lond), 2002; 103 Suppl 48: 9S-12S
47. Minami M, Kume N, Kataoka H, Morimoto M, Hayas-hida K, Sawamura T, Masaki T, Kita T: Transforming growth factor-beta(1) increases the expression of lectin-like oxidized low-density lipoprotein receptor-1. Bio-chem Biophys Res Commun, 2000; 272: 357-361
48. Shin HK, Kim YK, Kim KY, Lee JH, Hong KW: Rem-nant lipoprotein particles induce apoptosis in endothe-lial cells by NAD(P)H oxidase-mediated production of superoxide and cytokines via lectin-like oxidized low-density lipoprotein receptor-1 activation: prevention by cilostazol. Circulation, 2004; 109: 1022-1028
49. Aramaki Y, Mitsuoka H, Toyohara M, Jinnai T, Kanatani K, Nakajima K, Mukai E, Yamada Y, Kita T, Inagaki N, Kume N: Lectin-like oxidized LDL receptor-1 (LOX-1) acts as a receptor for remnant-like lipoprotein particles (RLPs) and mediates RLP-induced migration of vascular smooth muscle cells. Atherosclerosis, 2008; 198: 272-279
50. Iwai-Kanai E, Hasegawa K, Sawamura T, Fujita M, Yanazume T, Toyokuni S, Adachi S, Kihara Y, Sasayama S: Activation of lectin-like oxidized low-density lipopro-tein receptor-1 induces apoptosis in cultured neonatal rat cardiac myocytes. Circulation, 2001; 104: 2948-2954
51. Kume N, Moriwaki H, Kataoka H, Minami M, Murase T, Sawamura T, Masaki T, Kita T: Inducible expression of LOX-1, a novel receptor for oxidized LDL, in macro-phages and vascular smooth muscle cells. Ann N Y Acad Sci, 2000; 902: 323-327
52. Li L, Sawamura T, Renier G: Glucose enhances human macrophage LOX-1 expression: role for LOX-1 in glu-cose-induced macrophage foam cell formation. Circ Res, 2004; 94: 892-901
53. Moriwaki H, Kume N, Sawamura T, Aoyama T, Hoshi-kawa H, Ochi H, Nishi E, Masaki T, Kita T: Ligand specificity of LOX-1, a novel endothelial receptor for oxidized low density lipoprotein. Arterioscler Thromb Vasc Biol, 1998; 18: 1541-1547
54. Park H, Adsit FG, Boyington JC: The 1.4 angstrom crystal structure of the human oxidized low density lipo-protein receptor lox-1. J Biol Chem, 2005; 280: 13593-13599
55. Marsche G, Levak-Frank S, Quehenberger O, Heller R, Sattler W, Malle E: Identification of the human analog of SR-BI and LOX-1 as receptors for hypochlorite-mod-ified high density lipoprotein on human umbilical venous endothelial cells. Faseb J, 2001; 15: 1095-1097
56. Honjo M, Nakamura K, Yamashiro K, Kiryu J, Tanihara H, McEvoy LM, Honda Y, Butcher EC, Masaki T, Sawamura T: Lectin-like oxidized LDL receptor-1 is a cell-adhesion molecule involved in endotoxin-induced inflammation. Proc Natl Acad Sci U S A, 2003; 100: 1274-1279
57. Murphy JE, Tacon D, Tedbury PR, Hadden JM, Knowling S, Sawamura T, Peckham M, Phillips SE, Walker JH, Ponnambalam S: LOX-1 scavenger receptor mediates calcium-dependent recognition of phosphatidylserine and apoptotic cells. Biochem J, 2006; 393: 107-115
58. Jono T, Miyazaki A, Nagai R, Sawamura T, Kitamura T, Horiuchi S: Lectin-like oxidized low density lipoprotein receptor-1 (LOX-1) serves as an endothelial receptor for advanced glycation end products (AGE). FEBS Lett, 2002; 511: 170-174
59. Delneste Y, Magistrelli G, Gauchat J, Haeuw J, Aubry J, Nakamura K, Kawakami-Honda N, Goetsch L, Sawamura T, Bonnefoy J, Jeannin P: Involvement of LOX-1 in dendritic cell-mediated antigen cross-presen-tation. Immunity, 2002; 17: 353-362
60. Theriault JR, Mambula SS, Sawamura T, Stevenson MA, Calderwood SK: Extracellular HSP70 binding to surface receptors present on antigen presenting cells and endothelial/epithelial cells. FEBS Lett, 2005; 579: 1951-1960
61. Inoue N, Sawamura T: Lectin-like oxidized LDL recep-tor-1 as extracellular chaperone receptor: its versatile functions and human diseases. Methods, 2007; 43: 218-222
62. Chen M, Kakutani M, Naruko T, Ueda M, Narumiya S, Masaki T, Sawamura T: Activation-dependent surface expression of LOX-1 in human platelets. Biochem Bio-phys Res Commun, 2001; 282: 153-158
63. Moriwaki H, Kume N, Kataoka H, Murase T, Nishi E, Sawamura T, Masaki T, Kita T: Expression of lectin-like oxidized low density lipoprotein receptor-1 in human and murine macrophages: upregulated expression by TNF-alpha. FEBS Lett, 1998; 440: 29-32
64. Tsukamoto K, Kinoshita M, Kojima K, Mikuni Y, Kudo M, Mori M, Fujita M, Horie E, Shimazu N, Teramoto T: Synergically increased expression of CD36, CLA-1 and CD68, but not of SR-A and LOX-1, with the progres-sion to foam cells from macrophages. J Atheroscler Thromb, 2002; 9: 57-64
65. Manning-Tobin JJ, Moore KJ, Seimon TA, Bell SA, Sha-ruk M, Alvarez-Leite JI, de Winther MP, Tabas I, Free-man MW: Loss of SR-A and CD36 activity reduces ath-erosclerotic lesion complexity without abrogating foam cell formation in hyperlipidemic mice. Arterioscler Thromb Vasc Biol, 2009; 29: 19-26
66. Schaeffer DF, Riazy M, Parhar KS, Chen JH, Duronio V, Sawamura T, Steinbrecher UP: LOX-1 augments oxLDL uptake by lysophosphatidylcholine-stimulated murine macrophages but is not required for oxLDL clearance from plasma. J Lipid Res, 2009
67. Murphy JE, Vohra RS, Dunn S, Holloway ZG, Monaco AP, Homer-Vanniasinkam S, Walker JH, Ponnambalam S: Oxidised LDL internalisation by the LOX-1 scaven-ger receptor is dependent on a novel cytoplasmic motif and is regulated by dynamin-2. J Cell Sci, 2008; 121: 2136-2147
68. Mehta JL, Li DY: Identification and autoregulation of receptor for OX-LDL in cultured human coronary artery endothelial cells. Biochem Biophys Res Commun, 1998; 248: 511-514.
69. Li D, Mehta JL: Intracellular signaling of LOX-1 in endothelial cell apoptosis. Circ Res, 2009; 104: 566-568
70. Galle J, Heinloth A, Wanner C, Heermeier K: Dual effect of oxidized LDL on cell cycle in human endothe-lial cells through oxidative stress. Kidney Int Suppl, 2001; 78: S120-123
71. Seibold S, Schurle D, Heinloth A, Wolf G, Wagner M, Galle J: Oxidized LDL induces proliferation and hyper-trophy in human umbilical vein endothelial cells via reg-ulation of p27Kip1 expression: role of RhoA. J Am Soc Nephrol, 2004; 15: 3026-3034
72. Li D, Liu L, Chen H, Sawamura T, Ranganathan S, Mehta JL: LOX-1 mediates oxidized low-density lipo-protein-induced expression of matrix metalloproteinases in human coronary artery endothelial cells. Circulation, 2003; 107: 612-617
73. Cominacini L, Rigoni A, Pasini AF, Garbin U, Davoli A, Campagnola M, Pastorino AM, Lo Cascio V, Sawamura T: The binding of oxidized low density lipoprotein (ox-LDL) to ox-LDL receptor-1 reduces the intracellular con-centration of nitric oxide in endothelial cells through an increased production of superoxide. J Biol Chem, 2001; 276: 13750-13755
74. Dandapat A, Hu C, Sun L, Mehta JL: Small concentra-tions of oxLDL induce capillary tube formation from endothelial cells via LOX-1-dependent redox-sensitive pathway. Arterioscler Thromb Vasc Biol, 2007; 27:2435-2442
75. Thum T, Borlak J: Mechanistic role of cytochrome P450 monooxygenases in oxidized low-density lipoprotein-induced vascular injury: therapy through LOX-1 recep-tor antagonism? Circ Res, 2004; 94: e1-13
76. Thum T, Borlak J: LOX-1 receptor blockade abrogates oxLDL-induced oxidative DNA damage and prevents activation of the transcriptional repressor Oct-1 in human coronary arterial endothelium. J Biol Chem, 2008; 283: 19456-19464
77. Li D, Saldeen T, Romeo F, Mehta JL: Oxidized LDL upregulates angiotensin II type 1 receptor expression in cultured human coronary artery endothelial cells: the potential role of transcription factor NF-kappaB. Circu-lation, 2000; 102: 1970-1976
78. Tanigawa H, Miura S, Zhang B, Uehara Y, Matsuo Y, Fujino M, Sawamura T, Saku K: Low-density lipopro-tein oxidized to various degrees activates ERK1/2 through Lox-1. Atherosclerosis, 2006; 188: 245-250
79. Sangle GV, Zhao R, Shen GX: Transmembrane signaling pathway mediates oxidized low-density lipoprotein-induced expression of plasminogen activator inhibitor-1 in vascular endothelial cells. Am J Physiol Endocrinol Metab, 2008; 295: E1243-1254
80. Cominacini L, Fratta Pasini A, Garbin U, Pastorino A, Rigoni A, Nava C, Davoli A, Lo Cascio V, Sawamura T: The platelet-endothelium interaction mediated by lec-tin-like oxidized low-density lipoprotein receptor-1 reduces the intracellular concentration of nitric oxide in endothelial cells. J Am Coll Cardiol, 2003; 41: 499-507
81. Li D, Chen H, Romeo F, Sawamura T, Saldeen T, Mehta JL: Statins modulate oxidized low-density lipoprotein-mediated adhesion molecule expression in human coro-nary artery endothelial cells: role of LOX-1. J Pharmacol Exp Ther, 2002; 302: 601-605.
82. 2+ signaling pathways in endothelial cells. J Cell Physiol, 2009; 220: 706-715
83. Mehta JL, Li DY, Chen HJ, Joseph J, Romeo F: Inhibi-tion of LOX-1 by statins may relate to upregulation of eNOS. Biochem Biophys Res Commun, 2001; 289: 857-861
84. Sugimoto K, Ishibashi T, Sawamura T, Inoue N, Kami-oka M, Uekita H, Ohkawara H, Sakamoto T, Sakamoto N, Okamoto Y, Takuwa Y, Kakino A, Fujita Y, Tanaka T, Teramoto T, Maruyama Y, Takeishi Y: LOX-1-MT1-MMP axis is crucial for RhoA and Rac1 activation induced by oxidized low-density lipoprotein in endothe-lial cells. Cardiovasc Res, 2009
85. Mattaliano MD, Huard C, Cao W, Hill AA, Zhong W, Martinez RV, Harnish DC, Paulsen JE, Shih HH: LOX-1-dependent transcriptional regulation in response to oxidized LDL treatment of human aortic endothelial cells. Am J Physiol Cell Physiol, 2009; 296: C1329-1337
86. Kataoka H, Kume N, Miyamoto S, Minami M, Morim-oto M, Hayashida K, Hashimoto N, Kita T: Oxi-dized LDL modulates Bax/Bcl-2 through the lectinlike Ox-LDL receptor-1 in vascular smooth muscle cells. Arterioscler Thromb Vasc Biol, 2001; 21: 955-960
87. Chen J, Mehta JL, Haider N, Zhang X, Narula J, Li D: Role of caspases in Ox-LDL-induced apoptotic cascade in human coronary artery endothelial cells. Circ Res, 2004; 94: 370-376
88. Fujita Y, Kakino A, Nishimichi N, Yamaguchi S, Sato Y, Machida S, Cominacini L, Delneste Y, Matsuda H, Sawamura T: Oxidized LDL receptor LOX-1 binds to C-reactive protein and mediates its vascular effects. Clin Chem, 2009; 55: 285-294
89. Kanata S, Akagi M, Nishimura S, Hayakawa S, Yoshida K, Sawamura T, Munakata H, Hamanishi C: Oxidized LDL binding to LOX-1 upregulates VEGF expression in cultured bovine chondrocytes through activation of PPAR-gamma. Biochem Biophys Res Commun, 2006; 348: 1003-1010
90. Mehta JL, Chen J, Hermonat PL, Romeo F, Novelli G: Lectin-like, oxidized low-density lipoprotein receptor-1 (LOX-1): a critical player in the development of athero-sclerosis and related disorders. Cardiovasc Res, 2006; 69: 36-45
91. Ando K, Fujita T: Role of lectin-like oxidized low-den-sity lipoprotein receptor-1 (LOX-1) in the development of hypertensive organ damage. Clin Exp Nephrol, 2004; 8: 178-182
92. Li D, Williams V, Liu L, Chen H, Sawamura T, Antakli T, Mehta JL: LOX-1 inhibition in myocardial ischemia-reperfusion injury: modulation of MMP-1 and inflam-mation. Am J Physiol Heart Circ Physiol, 2002; 283: H1795-801
93. Li D, Williams V, Liu L, Chen H, Sawamura T, Romeo F, Mehta JL: Expression of lectin-like oxidized low-density lipoprotein receptors during ischemia-reperfusion and its role in determination of apoptosis and left ventricular dysfunction. J Am Coll Cardiol, 2003; 41: 1048-1055
94. Mehta JL, Sanada N, Hu CP, Chen J, Dandapat A, Sug-awara F, Satoh H, Inoue K, Kawase Y, Jishage K, Suzuki H, Takeya M, Schnackenberg L, Beger R, Hermonat PL, Thomas M, Sawamura T: Deletion of LOX-1 reduces atherogenesis in LDLR knockout mice fed high choles-terol diet. Circ Res, 2007; 100: 1634-1642
95. Inoue K, Arai Y, Kurihara H, Kita T, Sawamura T: Over-expression of lectin-like oxidized low-density lipoprotein receptor-1 induces intramyocardial vasculopathy in apo-lipoprotein E-null mice. Circ Res, 2005; 97: 176-184
96. Hu C, Dandapat A, Chen J, Fujita Y, Inoue N, Kawase Y, Jishage K, Suzuki H, Sawamura T, Mehta JL: LOX-1 deletion alters signals of myocardial remodeling immedi-ately after ischemia-reperfusion. Cardiovasc Res, 2007; 76: 292-302
97. Hu C, Chen J, Dandapat A, Fujita Y, Inoue N, Kawase Y, Jishage K, Suzuki H, Li D, Hermonat PL, Sawamura T, Mehta JL: LOX-1 abrogation reduces myocardial isch-emia-reperfusion injury in mice. J Mol Cell Cardiol, 2008; 44: 76-83
98. Li DY, Chen HJ, Staples ED, Ozaki K, Annex B, Singh BK, Vermani R, Mehta JL: Oxidized low-density lipo-protein receptor LOX-1 and apoptosis in human athero-sclerotic lesions. J Cardiovasc Pharmacol Ther, 2002; 7: 147-153
99. Ishino S, Mukai T, Kume N, Asano D, Ogawa M, Kuge Y, Minami M, Kita T, Shiomi M, Saji H: Lectin-like oxi-dized LDL receptor-1 (LOX-1) expression is associated with atherosclerotic plaque instability--analysis in hyper-cholesterolemic rabbits. Atherosclerosis, 2007; 195: 48-56
100. Kuge Y, Kume N, Ishino S, Takai N, Ogawa Y, Mukai T, Minami M, Shiomi M, Saji H: Prominent lectin-like oxidized low density lipoprotein (LDL) receptor-1 (LOX-1) expression in atherosclerotic lesions is associ-ated with tissue factor expression and apoptosis in hyper-cholesterolemic rabbits. Biol Pharm Bull, 2008; 31: 1475-1482
101. Ishino S, Mukai T, Kuge Y, Kume N, Ogawa M, Takai N, Kamihashi J, Shiomi M, Minami M, Kita T, Saji H: Tar-geting of lectinlike oxidized low-density lipoprotein receptor 1 (LOX-1) with 99mTc-labeled anti-LOX-1 antibody: potential agent for imaging of vulnerable plaque. J Nucl Med, 2008; 49: 1677-1685
102. Hayashida K, Kume N, Murase T, Minami M, Nak-agawa D, Inada T, Tanaka M, Ueda A, Kominami G, Kambara H, Kimura T, Kita T: Serum soluble lectin-like oxidized low-density lipoprotein receptor-1 levels are elevated in acute coronary syndrome: a novel marker for early diagnosis. Circulation, 2005; 112: 812-818
103. Kamezaki F, Yamashita K, Tasaki H, Kume N, Mitsuoka H, Kita T, Adachi T, Otsuji Y: Serum soluble lectin-like oxidized low-density lipoprotein receptor-1 correlates with oxidative stress markers in stable coronary artery disease. Int J Cardiol, 2009; 134: 285-287
104. Lubrano V, Del Turco S, Nicolini G, Di Cecco P, Basta G: Circulating levels of lectin-like oxidized low-density lipoprotein receptor-1 are associated with inflammatory markers. Lipids, 2008; 43: 945-950
105. Brinkley TE, Kume N, Mitsuoka H, Phares DA, Hag-berg JM: Elevated soluble lectin-like oxidized LDL receptor-1 (sLOX-1) levels in obese postmenopausal women. Obesity (Silver Spring), 2008; 16: 1454-1456
106. Brinkley TE, Kume N, Mitsuoka H, Brown MD, Phares DA, Ferrell RE, Kita T, Hagberg JM: Variation in the human lectin-like oxidized low-density lipoprotein receptor 1 (LOX-1) gene is associated with plasma solu-ble LOX-1 levels. Exp Physiol, 2008; 93: 1085-1090
107. Renier G: Lectin-like oxidized low-density lipoprotein receptor-1 (LOX-1), a relevant target for diabetic vascu-lopathy? Cardiovasc Hematol Disord Drug Targets, 2008; 8: 203-211
108. Nagase M, Kaname S, Nagase T, Wang G, Ando K, Sawamura T, Fujita T: Expression of LOX-1, an oxidized low-density lipoprotein receptor, in experimental hyper-tensive glomerulosclerosis. J Am Soc Nephrol, 2000; 11: 1826-1836
109. Mehta JL, Hu B, Chen J, Li D: Pioglitazone inhibits LOX-1 expression in human coronary artery endothelial cells by reducing intracellular superoxide radical genera-tion. Arterioscler Thromb Vasc Biol, 2003; 23: 2203-2208
110. Chen H, Li D, Sawamura T, Inoue K, Mehta JL: Upreg-ulation of LOX-1 expression in aorta of hypercholester-olemic rabbits: modulation by losartan. Biochem Bio-phys Res Commun, 2000; 276: 1100-1104
111. Bai YP, Zhang GG, Shi RZ, Li YJ, Tan GS, Chen J: Inhibitory effect of reinioside C on LOX-1 expression induced by ox-LDL. Zhong Nan Da Xue Xue Bao Yi Xue Ban, 2006; 31: 659-662
112. Shibata Y, Kume N, Arai H, Hayashida K, Inui-Hayas-hida A, Minami M, Mukai E, Toyohara M, Harauma A, Murayama T, Kita T, Hara S, Kamei K, Yokode M: Mul-berry leaf aqueous fractions inhibit TNF-alpha-induced nuclear factor kappaB (NF-kappaB) activation and lec-tin-like oxidized LDL receptor-1 (LOX-1) expression in vascular endothelial cells. Atherosclerosis, 2007; 193: 20-27
113. Ouslimani N, Mahrouf M, Peynet J, Bonnefont-Rous-selot D, Cosson C, Legrand A, Beaudeux JL: Metformin reduces endothelial cell expression of both the receptor for advanced glycation end products and lectin-like oxi-dized receptor 1. Metabolism, 2007; 56: 308-313
114. Wang LJ, Yu YH, Zhang LG, Wang Y, Niu N, Li Q, Guo LM: Taurine rescues vascular endothelial dysfunc-tion in streptozocin-induced diabetic rats: correlated with downregulation of LOX-1 and ICAM-1 expression on aortas. Eur J Pharmacol, 2008; 597: 75-80
115. Li DY, Chen HJ, Mehta JL: Statins inhibit oxidized-LDL-mediated LOX-1 expression, uptake of oxidized-LDL and reduction in PKB phosphorylation. Cardiovasc Res, 2001; 52: 130-135
116. Takayama M, Matsubara M, Arakawa E, Takada C, Ina Y, Hasegawa K, Yao K: Comparison of the antiatheroscle-rotic effects of dihydropyridine calcium channel blocker and HMG-CoA reductase inhibitor on hypercholesterol-emic rabbits. Vascul Pharmacol, 2007; 46: 302-308
117. Mehta JL, Chen J, Yu F, Li DY: Aspirin inhibits ox-LDL-mediated LOX-1 expression and metalloproteinase-1 in human coronary endothelial cells. Cardiovasc Res, 2004; 64: 243-249
118. Marwali MR, Hu CP, Mohandas B, Dandapat A, Deon-ikar P, Chen J, Cawich I, Sawamura T, Kavdia M, Mehta JL: Modulation of ADP-induced platelet activation by aspirin and pravastatin: role of lectin-like oxidized low-density lipoprotein receptor-1, nitric oxide, oxidative stress, and inside-out integrin signaling. J Pharmacol Exp Ther, 2007; 322: 1324-1332